Nutraceutical brands sit in the high-risk category, so the card networks watch their payments closely. Visa's VAMP program and Mastercard's chargeback monitoring set hard ceilings on a brand's dispute and chargeback ratios.

A brand scaling fast is the exact profile that trips those ceilings. A young account has almost no processing history to absorb a spike in declines or disputes, so the harder acquisition pushes, the faster the ratios climb toward the limit.

Dunning management reworks the failed payments in the background, and active chargeback prevention keeps the dispute ratio under the thresholds that trigger a review.

Every transaction routes across several processors, so a decline on one path retries on another before it ever becomes a failed rebill.

That routing is why approvals held even at peak volume: 94.9% of direct sales and 92.7% of subscription rebills cleared.

Salvage logic reworks the failures in the background, and monitoring keeps the dispute signals under the thresholds that trigger a review. None of it needed a hire on the merchant's side.

The brand got to scale like a high-risk operator while its account behaved like a low-risk one by reducing chargebacks and keeping approval rates high.

How do you reduce chargebacks on a high-risk nutraceutical account?

The answer is clear but not always easy to implement: route across multiple processors so declines retry instead of failing, recover failed payments with dunning before they churn, and monitor the dispute ratio against the Visa VAMP threshold so growth doesn’t trip a review.

The merchant ran their offer on this exact infrastructure with Phoenix, which kept their revenue from leaking or payments getting throttled. Their non-stop scaling ended up allowing them to 10X and hit their first 7-figure quarter.

First eight months on Phoenix · 42,605 orders · 0.1% disputes